透过BRAF V600突变转移性肺癌病例，看精准靶向治疗之效果。 俗话说“兵来将挡，水来土掩”，问题总会有解决的办法。那么，对于预后较差的BRAF突变转移性NSCLC患者，临床实践中该如何应对呢？
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results